Loading…
Nuclear Medicine Clarification Act of 2023
Legislative Progress
Introduced
December 14, 2023
Latest Action
December 15, 2023
Primary Sponsor
H. Morgan GriffithRepublican(VA)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
53pct
1d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2024 · fourth_quarter · Health Issues
The Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023, HR 1199, S 1544 The Nuclear Medicine Clarification Act, HR 6815
Referred to the Subcommittee on Energy, Climate and Grid Security.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Nuclear Regulatory Commission (NRC), SENATE
2024 · fourth_quarter · Health Issues
Issues related to patient access to radiation therapy and imaging services. H.R.6815 - Nuclear Medicine Clarification Act of 2023
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Energy/Nuclear
H.R. 8046 - Rosatom Sanctions Enforcement Act H.R. 6395 - Recognizing the Importance of Critical Minerals in Healthcare Act of 2023 H.R. 6815 - Nuclear Medicine Clarification Act Proposed legislation to reauthorize the DOE Isotope Program Appropriations for DOE isotope production NRC rules impacting the use of radiopharmaceuticals
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Energy/Nuclear
Issues related to the Nuclear Regulatory Commission's preliminary proposed rule titled, "Reporting Nuclear Medicine Injection Extravasations as Medical Events" (10 CFR 35). Issues related to the Nuclear Medicine Clarification Act (H.R. 6815, 118th Congress).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
The Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023, HR 1199, S 1544 The Nuclear Medicine Clarification Act, HR 6815
Client expense: $60,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Nuclear Regulatory Commission (NRC), SENATE
2024 · third_quarter · Health Issues
Issues related to patient access to radiation therapy and imaging services. H.R.6815 - Nuclear Medicine Clarification Act of 2023
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Energy/Nuclear
H.R. 8046 - Rosatom Sanctions Enforcement Act H.R. 6395 - Recognizing the Importance of Critical Minerals in Healthcare Act of 2023 H.R. 6815 - Nuclear Medicine Clarification Act Proposed legislation to reauthorize the DOE Isotope Program Appropriations for DOE isotope production NRC rules impacting the use of radiopharmaceuticals
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Energy/Nuclear
Issues related to the Nuclear Regulatory Commission's preliminary proposed rule titled, "Reporting Nuclear Medicine Injection Extravasations as Medical Events" (10 CFR 35). Issues related to the Nuclear Medicine Clarification Act (H.R. 6815).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Energy/Nuclear
H.R. 8046 - Rosatom Sanctions Enforcement Act H.R. 6395 - Recognizing the Importance of Critical Minerals in Healthcare Act of 2023 H.R. 6815 - Nuclear Medicine Clarification Act Proposed legislation to reauthorize the DOE Isotope Program Appropriations for DOE isotope production NRC rules impacting the use of radiopharmaceuticals
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
Issues related to patient access to radiation therapy and imaging services. H.R.6815 - Nuclear Medicine Clarification Act of 2023
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Energy/Nuclear
Issues related to the Nuclear Regulatory Commission's preliminary proposed rule titled, "Reporting Nuclear Medicine Injection Extravasations as Medical Events" (10 CFR 35). Issues related to the Nuclear Medicine Clarification Act (H.R. 6815).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Health Issues
Issues related to patient access to radiation therapy and imaging services. H.R.6815 - Nuclear Medicine Clarification Act of 2023
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| FL |
| Deborah K. Ross | Democratic | NC |
| Donald G. Davis | Democratic | NC |
| Jason Crow | Democratic | CO |
| Joe Neguse | Democratic | CO |
| John H. Rutherford | Republican | FL |
| John P. Sarbanes | Democratic | MD |
| Mike Levin | Democratic | CA |
| Paul Tonko | Democratic | NY |
| Richard McCormick | Republican | GA |
| Salud O. Carbajal | Democratic | CA |
| Valerie P. Foushee | Democratic | NC |
| Wiley Nickel | Democratic | NC |